PLoS ONE (Jan 2014)

Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.

  • Rie Nakamoto-Matsubara,
  • Mamiko Sakata-Yanagimoto,
  • Terukazu Enami,
  • Kenichi Yoshida,
  • Shintaro Yanagimoto,
  • Yusuke Shiozawa,
  • Tohru Nanmoku,
  • Kaishi Satomi,
  • Hideharu Muto,
  • Naoshi Obara,
  • Takayasu Kato,
  • Naoki Kurita,
  • Yasuhisa Yokoyama,
  • Koji Izutsu,
  • Yasunori Ota,
  • Masashi Sanada,
  • Seiichi Shimizu,
  • Takuya Komeno,
  • Yuji Sato,
  • Takayoshi Ito,
  • Issay Kitabayashi,
  • Kengo Takeuchi,
  • Naoya Nakamura,
  • Seishi Ogawa,
  • Shigeru Chiba

DOI
https://doi.org/10.1371/journal.pone.0109714
Journal volume & issue
Vol. 9, no. 10
p. e109714

Abstract

Read online

Angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) are subtypes of T-cell lymphoma. Due to low tumor cell content and substantial reactive cell infiltration, these lymphomas are sometimes mistaken for other types of lymphomas or even non-neoplastic diseases. In addition, a significant proportion of PTCL-NOS cases reportedly exhibit features of AITL (AITL-like PTCL-NOS). Thus disagreement is common in distinguishing between AITL and PTCL-NOS. Using whole-exome and subsequent targeted sequencing, we recently identified G17V RHOA mutations in 60-70% of AITL and AITL-like PTCL-NOS cases but not in other hematologic cancers, including other T-cell malignancies. Here, we establish a sensitive detection method for the G17V RHOA mutation using a quantitative allele-specific polymerase chain reaction (qAS-PCR) assay. Mutated allele frequencies deduced from this approach were highly correlated with those determined by deep sequencing. This method could serve as a novel diagnostic tool for 60-70% of AITL and AITL-like PTCL-NOS.